β1 integrin deletion enhances progression of prostate cancer in the TRAMP mouse model

被引:16
|
作者
Moran-Jones, Kim [1 ]
Ledger, Anita [1 ]
Naylor, Matthew J. [1 ,2 ,3 ]
机构
[1] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
[2] Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia
[3] Univ Sydney, Sch Med Sci, Bosch Inst, Sydney, NSW 2006, Australia
来源
SCIENTIFIC REPORTS | 2012年 / 2卷
基金
英国医学研究理事会;
关键词
BETA(1A) INTEGRIN EXPRESSION; ALPHA(2)BETA(1) INTEGRIN; TERMINAL DIFFERENTIATION; 3-DIMENSIONAL CULTURES; CELL-PROLIFERATION; TRANSGENIC MOUSE; MAMMARY-GLAND; IN-VIVO; GROWTH; PROTEIN;
D O I
10.1038/srep00526
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
beta 1 integrin regulates the response of both normal and cancer cells to their local environment. Although mis-localised in prostate cancer, the role beta 1 integrin plays in prostate development and carcinogenesis remains unknown. To assess the role of beta 1 integrin in vivo, we conditionally deleted beta 1 integrin from prostate epithelium and subsequently crossed these mice to the TRAMP prostate carcinogenesis model. Deletion of beta 1 integrin following castration and subsequent androgen supplementation resulted in an expansion of the p63-positive basal cell population and decreased differentiation. Consistent with these findings, deletion of beta 1 integrin in TRAMP mice decreased animal survival, decreased retention of normal prostate morphology, increased the percentage of tissue with poorly differentiated carcinoma, and increased cell proliferation. This study demonstrates that beta 1 integrin regulates several aspects of normal prostate development and in contrast to its role in several other tissues, its loss is associated with increased rates of prostate tumour progression.
引用
下载
收藏
页数:7
相关论文
共 50 条
  • [1] β1 integrin deletion enhances progression of prostate cancer in the TRAMP mouse model
    Kim Moran-Jones
    Anita Ledger
    Matthew J. Naylor
    Scientific Reports, 2
  • [2] Pathologic progression of autochthonous prostate cancer in the TRAMP model
    JR Gingrich
    RJ Barrios
    BA Foster
    NM Greenberg
    Prostate Cancer and Prostatic Diseases, 1999, 2 : 70 - 75
  • [3] Pathologic progression of autochthonous prostate cancer in the TRAMP model
    Gingrich, JR
    Barrios, RJ
    Foster, BA
    Greenberg, NM
    PROSTATE CANCER AND PROSTATIC DISEASES, 1999, 2 (02) : 70 - 75
  • [4] Central tolerance in a prostate cancer model TRAMP mouse
    Zheng, P
    Zheng, XC
    Gao, JX
    Zhang, HM
    Geiger, T
    Liu, Y
    IMMUNE MECHANISMS AND DISEASE, 2003, 987 : 322 - 323
  • [5] Iodine Uptake and Prostate Cancer in the TRAMP Mouse Model
    Paloma Olvera-Caltzontzin
    Guadalupe Delgado
    Carmen Aceves
    Brenda Anguiano
    Molecular Medicine, 2013, 19 : 409 - 416
  • [6] Iodine Uptake and Prostate Cancer in the TRAMP Mouse Model
    Olvera-Caltzontzin, Paloma
    Delgado, Guadalupe
    Aceves, Carmen
    Anguiano, Brenda
    MOLECULAR MEDICINE, 2013, 19 : 409 - 416
  • [7] Dietary Zinc and Prostate Cancer in the TRAMP Mouse Model
    Prasad, Ananda S.
    Mukhtar, Hasan
    Beck, Frances W. J.
    Adhami, Vaqar M.
    Siddiqui, Imtiaz A.
    Din, Maria
    Hafeez, Bilal B.
    Kucuk, Omer
    JOURNAL OF MEDICINAL FOOD, 2010, 13 (01) : 70 - 76
  • [8] Olfactomedin 4 deficiency promote de novo progression of prostate cancer in TRAMP mouse model
    Li, Hongzhen
    Liu, Wenli
    Zhu, Jianqiong
    Chin, Kyung
    Rodgers, Griffin P.
    CANCER RESEARCH, 2024, 84 (06)
  • [9] Prevention of prostate cancer progression with vitamin D compounds in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
    Alagbala, AA
    Moser, MT
    Johnson, CS
    Trump, DL
    Posner, GH
    Foster, BA
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (11) : 2716S - 2716S
  • [10] How the TRAMP Model Revolutionized the Study of Prostate Cancer Progression
    Gelman, Irwin H.
    CANCER RESEARCH, 2016, 76 (21) : 6137 - 6139